Belgium is famous for its political dysfunction — a record 541 days without a government in 2010, perpetual coalition crises, three linguistic communities pulling in different directions. Yet this same country quietly enacted one of Europe's most inclusive reproductive laws and built a fertility treatment infrastructure that draws patients from across the continent. The contrast is not accidental. In the absence of strong centralising political authority, Belgium developed a pragmatic pluralism in its institutions — including medicine. What was too politically sensitive to restrict was simply left open.
Today Belgium is one of the primary reproductive tourism destinations in Europe, particularly for French-speaking patients. Belgian clinics have invested heavily in multilingual infrastructure, short waiting lists, and patient-centred care pathways. The country sits at a geographical and cultural crossroads: 1 hour 20 minutes by Eurostar from London, the same from Paris, 2 hours from Amsterdam. This accessibility is not incidental — it has shaped the entire clinical economy of Belgian fertility medicine.
Belgium's law on assisted reproduction — the Loi relative à la procréation médicalement assistée — was adopted in 2007. It remains one of the most permissive ART frameworks in the European Union. The law explicitly permits treatment for single women, same-sex female couples, and heterosexual couples (married or unmarried). No minimum or maximum age for recipients is written into statute — this decision is left to the treating physician and the clinical ethics committee.
Two aspects distinguish Belgium's law from many of its neighbours. First, access is explicitly stated as non-discriminatory by family structure. Second, the law establishes a positive right to treatment, not merely an absence of prohibition. Germany still restricts egg donation entirely. France opened access to single women and same-sex couples only in 2021, after decades of campaigning. Austria has complex restrictions. Spain has a permissive law but with anonymous donation. Belgium sits in a distinct category: open donation, wide access, university-level clinical infrastructure, and a track record of treating patients from across Europe.
Before 2019, Belgium operated a fully anonymous donation system. Egg and sperm donors could not be identified by the children born from their genetic material. The 2019 legislative reform changed this fundamentally: all donations registered after the reform now require the donor's consent to potential future disclosure of their identifying data.
The transition was better managed than critics had feared. Belgian fertility centres prepared well in advance, updating their donor recruitment frameworks and consent processes. Most new donors now register with an explicit understanding that their biological offspring may contact them once the child turns 18.
France's ART history is instructive. For decades, French law permitted IVF only for heterosexual couples in a stable relationship. Single women, lesbian couples, and non-standard family structures were legally excluded. Belgium became their natural destination: close, French-speaking across Wallonia and Brussels, and fully equipped clinically.
The 2021 Loi de bioéthique changed the French landscape significantly, opening access to single women and same-sex female couples for the first time. Some Belgian clinics anticipated a sharp decline in French patient volume. It did not materialise to the expected degree — and the reason reveals something important about how reproductive medicine actually works in practice.
Belgium has one of Europe's more generous IVF reimbursement schemes — for residents. The national health insurance body (INAMI in French, RIZIV in Dutch) covers up to six complete IVF cycles for women under 43 with a recognised medical indication. Coverage includes stimulation medications and the embryo transfer, with a modest patient co-payment. This subsidy is available only to Belgian citizens and registered residents; foreign patients pay in full.
| Treatment | Typical price (EUR) |
|---|---|
| Own IVF cycle (full) | 2,800–4,500 |
| Donor egg cycle (full) | 4,500–7,000 |
| Donor sperm per cycle | 700–1,400 |
| PGT-A add-on (embryo screening) | +1,500–2,500 |
| FET (frozen embryo transfer) | 800–1,500 |
For patients combining multiple treatments — PGT-A plus donor sperm, for instance — total costs can approach €7,000–9,000. Belgian clinics generally provide detailed written estimates before treatment begins, with itemised cost breakdowns. This transparency is a practical advantage: patients report fewer unexpected charges than at some other European destinations. Budget separately for travel and accommodation: Brussels, Ghent, and Leuven are moderately expensive cities, though below London or Paris levels.
Belgium has a moderate but functional donor pool by European standards. The 2019 transition to open donation did not cause the collapse that some predicted — the experience mirrors what happened in the UK (which ended anonymity in 2005) and the Netherlands (2004): an initial dip in donor numbers followed by stabilisation as a new cohort of altruistically motivated donors emerged.
Waiting times for egg donation currently run 2–5 months depending on the centre and the requested donor phenotype. Sperm donation has shorter waiting times. Phenotypic matching — hair colour, eye colour, skin tone, build — is standard practice across all major Belgian fertility centres. Some centres, particularly UZ Gent and UZ Leuven, offer expanded genomic carrier screening of donors as an optional add-on, which is especially relevant for patients with known carrier status for specific conditions such as cystic fibrosis, spinal muscular atrophy, or fragile X syndrome.
Belgium's fertility sector is dominated by university hospital fertility centres. This matters clinically: university hospitals combine high patient volume with active research programmes, specialist staff, and institutional ethics committees. The four most established centres are:
UZ Gent (Ghent University Hospital) — one of Belgium's highest-volume centres with a long track record in donor egg cycles and strong embryology laboratory metrics. Primarily Dutch-speaking, with dedicated English-language international patient services.
UZ Leuven (KU Leuven University Hospital) — one of the leading European centres for preimplantation genetic testing. Significant published research output in reproductive genetics. Dutch-speaking with well-developed international patient pathways.
VUB Universitair Ziekenhuis Brussel — Brussels-based, serving both Dutch- and French-speaking populations. Conveniently located for patients arriving via Brussels-Midi station, which is the Eurostar, Thalys, and Eurostar terminus.
Centre PMA ULiège (University of Liège) — the primary Francophone academic fertility centre in Belgium. Particularly attractive for French patients not only linguistically but geographically: Liège is 1h10 from Paris by TGV. The centre has a strong reputation in complex cases including recurrent implantation failure and male factor infertility.
All four centres are federally licensed, submit outcome data to the national embryo register, and operate under institutional ethics committee oversight. Published live birth rate statistics are available for benchmarking.
Belgium is notable among European countries for the breadth of family structures explicitly covered by its ART law. The 2007 Act does not define a minimum family unit — it defines categories of access. Within those categories, diverse configurations are possible.
For co-parenting arrangements — where two individuals not in a romantic relationship intend to jointly raise a child — Belgian law is less explicitly developed. Belgian civil law does not yet have a dedicated co-parenting registration framework comparable to what some jurisdictions are building. In practice, fertility clinics require clear identification of the legal intended parent(s) and, where a donor is known to the recipients, specific legal documentation.
Surrogacy in Belgium sits in a grey zone. The 2007 Act neither prohibits nor regulates it. Some Belgian clinics — notably UZ Gent and VUB — accept carefully screened altruistic surrogacy cases under their internal protocols and ethics committee oversight. All such arrangements are altruistic; commercial surrogacy is not available. Legal outcomes for the intended parents vary and require specialist legal advice.
Belgium is one of the most accessible European countries for medical travel, and Belgian fertility clinics have developed well-optimised cross-border patient pathways.
Getting there: Brussels-Midi is served by Eurostar from London St Pancras (2 hours), direct Eurostar/Thalys from Paris-Nord (1h22), direct trains from Amsterdam Centraal (1h47) and from Cologne (1h47). From Brussels, Ghent is 30 minutes by domestic train and Leuven is 25 minutes. Liège (for ULiège patients) is 1h10 from Paris-Est by TGV.
How the process typically works: Most Belgian centres now offer a remote initial consultation — no travel required for the first assessment. Baseline blood tests (AMH, FSH, AFC ultrasound) can usually be performed at your home clinic and results submitted electronically. The waiting list begins after the first remote consultation.
Documents to prepare: Previous fertility workup results (AMH, AFC, semen analysis if applicable), blood group and screen, rubella and hepatitis status, any previous treatment records. Belgian centres work in French, Dutch, and English — language is rarely a barrier.